<?xml version="1.0" encoding="UTF-8" ?>
<Event Id="13570369" lastUpdate="Tuesday, December 29, 2020 at 1:15:47am GMT" eventTypeId="5" eventTypeName="Corporate Conference Call/Presentation">
  <EventStory Id="13570369.F" expirationDate="Monday, December 28, 2020 at 1:30:00pm GMT" action="publish" storyType="transcript" version="Final">
    <Headline><![CDATA[Edited Transcript of MYOV.N conference call or presentation 28-Dec-20 1:30pm GMT]]></Headline>
    <Body><![CDATA[Myovant Sciences Ltd and Pfizer Inc Collaboration To Develop and Commercialize Relugolix in Oncology and Women’s Health Call

NEW YORK Dec 29, 2020 (Thomson StreetEvents) -- Edited Transcript of Myovant Sciences Ltd conference call or presentation Monday, December 28, 2020 at 1:30:00pm GMT

TEXT version of Transcript

]]></Body>
  </EventStory>
  <eventTitle><![CDATA[Myovant Sciences Ltd and Pfizer Inc Collaboration To Develop and Commercialize Relugolix in Oncology and Women’s Health Call]]></eventTitle>
  <city>NEW YORK</city>
  <companyName>Myovant Sciences Ltd</companyName>
  <companyTicker>MYOV.N</companyTicker>
  <startDate>28-Dec-20 1:30pm GMT</startDate>
</Event>